Atopic Dermatitis
The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.
Latest News
Biomarker Insights Differentiate JAK1 vs IL-13 Therapy in AD
September 10th 2025
AD-related outcomes were compared in patients treated with JAK1 inhibitors and IL-13 antibodies, with short-term efficacy biomarkers considered for treatment outcomes.
Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access
Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.
